The COVID-19 impact on severe uncontrolled asthma costs and biologic use.

Khan NS, Rubin E, McKenna B, Palowitch BL, Sonnenberg F, Argon J, Panettieri RA Jr

Open source

DOI
10.2500/aap.2023.44.230045
Published
2023 Sep 1
Container
Allergy and asthma proceedings
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2500/aap.2023.44.230045,
  title = {The COVID-19 impact on severe uncontrolled asthma costs and biologic use.},
  author = {Khan NS and Rubin E and McKenna B and Palowitch BL and Sonnenberg F and Argon J and Panettieri RA Jr},
  year = {2023},
  journal = {Allergy and asthma proceedings},
  doi = {10.2500/aap.2023.44.230045},
  url = {https://doi.org/10.2500/aap.2023.44.230045}
}

RIS

TY  - JOUR
TI  - The COVID-19 impact on severe uncontrolled asthma costs and biologic use.
AU  - Khan NS
AU  - Rubin E
AU  - McKenna B
AU  - Palowitch BL
AU  - Sonnenberg F
AU  - Argon J
AU  - Panettieri RA Jr
PY  - 2023
JO  - Allergy and asthma proceedings
DO  - 10.2500/aap.2023.44.230045
UR  - https://doi.org/10.2500/aap.2023.44.230045
ER  - 

APA

NS, K., E, R., B, M., BL, P., F, S., J, A., & Jr, P. R. (2023). The COVID-19 impact on severe uncontrolled asthma costs and biologic use.. Allergy and asthma proceedings. https://doi.org/10.2500/aap.2023.44.230045

Source records